Work

Divergence between progression-free and overall survival treatment effect sizes in antibody-drug conjugate trials: A meta-epidemiologic study.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e13076

Authors: Andreia Cristina de Melo, Luiz F. Costa De Almeida, Anelise Poluboiarinov Cappellaro, Mariana Macambira Noronha, Lucas Diniz da Conceição, Paolo Tarantino, Dario Trapani, Felipe Batalini, Jesse Lopes da Silva

Institutions: Instituto Nacional de Câncer - INCA, Universidade Federal Fluminense, Universidade Federal do Ceará, Harvard University, Dana-Farber Cancer Institute, European Institute of Oncology, Mayo Clinic in Arizona, Mayo Clinic Hospital, Mayo Clinic Comprehensive Cancer Center (Arizona)

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162680798

Cites:

Cited by:

Related to: